Clinical Trials Logo
  1. Home
  2. Acute Migraine
  3. NCT03631550

The RIME Study - Combined Occipital and Supraorbital Transcutaneous Nerve Stimulation for Treatment of Migraine

Acute Migraine Clinical Trial

Official title:
The RIME Study - Combined Occipital and Supraorbital Transcutaneous Nerve Stimulation for Treatment of Migraine

Clinical Trial Summary

this study will evaluate the clinical performance and safety of a self administered abortive treatment for migraine headache using combined occipital and supraorbital transcutaneous nerve stimulator (Neurolief device, Relivion®)

Clinical Trial Description

The Relivion® is a non-invasive transcutaneous neuro-stimulator is indicated for the acute treatment of migraine with or without aura in subjects 18 years of age or older. The Relivion® is intended to be a prescription device, self-used at home. ;

Study Design

Related Conditions & MeSH terms

Clinical Trial Details
NCT number NCT03631550
Study type Interventional
Source Neurolief Ltd.
Contact
Status Completed
Phase N/A
Start date November 29, 2018
Completion date August 4, 2020
View Details
See also
  Status Clinical Trial Phase
Completed NCT04153409 - A Proof of Concept Study of the Efficacy and Safety of Oral LAT8881 in Acute Migraine Phase 2
Completed NCT02279082 - DFN-02 Open Label Safety Study in Patients With Acute Migraine Phase 3
Completed NCT04574362 - Safety and Efficacy Trial of BHV3000 (Rimegepant) 75 mg for the Acute Treatment of Migraine Phase 3
Completed NCT01973205 - Efficacy and Safety of Acetaminophen and Aspirin Versus Placebo in the Acute Treatment of Migraine Phase 3
Terminated NCT04089761 - Safety and Efficacy of Nerivio™ for the Acute Treatment of Migraine in Adolescents N/A
Completed NCT01267864 - Valproate Versus Ketorolac Versus Metoclopramide Phase 4
Completed NCT05371652 - A Study to Learn About the Long-term Safety of Rimegepant for the Acute Treatment of Migraine in Chinese Participants Phase 3
Completed NCT04218162 - Lasmiditan Compared to Placebo in the Acute Treatment of Migraine in Korean Phase 3
Completed NCT01730326 - Intravenous Dexketoprofen and Paracetamol in the Treatment of Headache Caused by Acute Migraine Attack Phase 4
Completed NCT04408794 - Long-term Safety Study of BHV-3500 (Zavegepant*) for the Acute Treatment of Migraine Phase 2/Phase 3
Completed NCT02745392 - Safety and Efficacy of ZP-Zolmitriptan Intracutaneous Microneedle Systems for the Acute Treatment of Migraine Phase 2/Phase 3
Completed NCT00894556 - A Study to Evaluate the Efficacy and Tolerability of Rizatriptan for Treatment of Acute Migraine (0462-087) Phase 3
Terminated NCT02185703 - Chordate System S020 Acute Migraine Clinical Investigation N/A
Terminated NCT01680029 - PBASE-system Acute Migraine Clinical Investigation N/A
Completed NCT01358279 - Transcranial Direct Current Stimulation for Migraine Attack N/A
Not yet recruiting NCT01228552 - The Efficacy and Safety of Intra-oral Topical Ketoprofen for the Treatment of Acute Migraine Phase 3
Completed NCT02684409 - Safety, Pharmacokinetic, and Tolerability Study of Zecuity® in Adolescent Subjects With a History of Acute Migraine Phase 1
Completed NCT02439320 - Lasmiditan Compared to Placebo in the Acute Treatment of Migraine: Phase 3
Terminated NCT01112553 - Treximet Migraine Brain Imaging Research Study N/A
Completed NCT01276977 - Zolmitriptan Nasal Spray Versus Eletriptan in the Acute Treatment of Migraine N/A